Review



vectra qmif staining  (Vectra Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Vectra Laboratories vectra qmif staining
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Vectra Qmif Staining, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/med_rxiv__64898__2026__01__10__26343859-158-11-11?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    vectra qmif staining - by Bioz Stars, 2026-07
    86/100 stars

    Images

    1) Product Images from "The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer"

    Article Title: The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer

    Journal: medRxiv

    doi: 10.64898/2026.01.10.26343859

    A. Representative high power fields from 1744 qmIF images used to compare the distribution of immune cells in tumor between nADT-treated duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Figure Legend Snippet: A. Representative high power fields from 1744 qmIF images used to compare the distribution of immune cells in tumor between nADT-treated duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).

    Techniques Used: Control, Marker



    Similar Products

    vectra qmif staining  (Vectra Laboratories)
    86
    Vectra Laboratories vectra qmif staining
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Vectra Qmif Staining, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/med_rxiv__64898__2026__01__10__26343859-158-11-11?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    vectra qmif staining - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    stain vectra multiplexed image  (Vectra Laboratories)
    86
    Vectra Laboratories stain vectra multiplexed image
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Stain Vectra Multiplexed Image, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pmc12871056-51-1-2?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    stain vectra multiplexed image - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    7 stain vectra image with dapi  (Vectra Laboratories)
    86
    Vectra Laboratories 7 stain vectra image with dapi
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    7 Stain Vectra Image With Dapi, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pmc12871056-101-9-10?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    7 stain vectra image with dapi - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    7 stain vectra tiff stack  (Vectra Laboratories)
    86
    Vectra Laboratories 7 stain vectra tiff stack
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    7 Stain Vectra Tiff Stack, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pmc12871056-52-37-38?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    7 stain vectra tiff stack - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    vectra polaris staining  (Vectra Laboratories)
    86
    Vectra Laboratories vectra polaris staining
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Vectra Polaris Staining, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pmc12824687-158-0-0?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    vectra polaris staining - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    vectra staining  (Vectra Laboratories)
    90
    Vectra Laboratories vectra staining
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Vectra Staining, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pmc12057687-117-38-38?v=Vectra+Laboratories
    Average 90 stars, based on 1 article reviews
    vectra staining - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    multiplex immunohistochemistry/ immunofluorescence stain using vectra system  (Vectra Laboratories)
    90
    Vectra Laboratories multiplex immunohistochemistry/ immunofluorescence stain using vectra system
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Multiplex Immunohistochemistry/ Immunofluorescence Stain Using Vectra System, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pm39360336-5-14-14?v=Vectra+Laboratories
    Average 90 stars, based on 1 article reviews
    multiplex immunohistochemistry/ immunofluorescence stain using vectra system - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    vectra multicolor staining  (Vectra Laboratories)
    86
    Vectra Laboratories vectra multicolor staining
    A. Representative high power fields from 1744 <t>qmIF</t> images used to compare the distribution of immune cells in tumor <t>between</t> <t>nADT-treated</t> duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).
    Vectra Multicolor Staining, supplied by Vectra Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vectra+staining/pm38218364-174-7-7?v=Vectra+Laboratories
    Average 86 stars, based on 1 article reviews
    vectra multicolor staining - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    A. Representative high power fields from 1744 qmIF images used to compare the distribution of immune cells in tumor between nADT-treated duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).

    Journal: medRxiv

    Article Title: The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer

    doi: 10.64898/2026.01.10.26343859

    Figure Lengend Snippet: A. Representative high power fields from 1744 qmIF images used to compare the distribution of immune cells in tumor between nADT-treated duration groups (≤ 2 months, 3-5 months, and ≥ 6 months) and matched control specimens. Marker identified by color indicated in inset, scale bar represents 20 µm. B. Bar charts quantitating changes in cell populations (as a percentage of total DAPI marked cells) for each duration nADT group (429, 356, 292 ROIs) vs matched control groups (322, 187, 158 ROIs). C. Stacked bars represent the proportion of each of the cell types (indicated in the color coded key below the stacked bar chart) for each nADT group and the matched control groups. D. Violin plots comparing the ratios of CTLs to M2-like TAMs (left) and CTLs to Tregs (right) in nADT-treated and control groups. Each data point represents the ratios from an individual patient sample, with comparisons made using the Wilcoxon signed-ranks test (+,*,**,*** indicates p-values of < 0.1, < 0.05; < 0.01; < 0.001, respectively).

    Article Snippet: Specifically, we compared tissues from the nADT and control cohorts using Vectra qmIF staining to determine immune cell proportions and spatial interactions, as diagrammed in .

    Techniques: Control, Marker